Pten Hamartoma Tumor Syndrome Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2017 | 77,388 | 46,489 | 30,899 | 12.6 | — |
| 2018 | 75,638 | 63,489 | 12,149 | 12.1 | — |
| 2019 | 53,075 | 58,147 | −5,072 | 12.3 | — |
| 2020 | 111,268 | 83,460 | 27,808 | 12.5 | — |
| 2021 | 89,913 | 62,254 | 27,659 | 22.1 | — |
| 2022 | 61,272 | 68,507 | −7,235 | 18.9 | — |
| 2023 | 74,081 | 66,701 | 7,380 | 20.7 | — |
In its most recent public year (2023), this organization brought in $7,380 more than it spent. Its reserves stood at about 20.7 months of spending, up from 12.6 in 2017.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Pten Hamartoma Tumor Syndrome Foundation's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works